Remco Evenepoel won't receive Covid-19 vaccination before Giro d'Italia in case of side effects
The Belgian will wait until after the Italian Grand Tour, not wanting to risk any side effects that could harm the build-up to his first race back from injury
Remco Evenepoel has decided to not receive a Covid-19 vaccine prior to the Giro d'Italia in case any side effects harm his preparation for the first race back since his Il Lombardia crash.
The 21-year-old would have had the option to get vaccinated next week, as part of the 170 Olympic and Paralympic Belgian athletes being offered a Pfizer or Moderna jab ahead of this summer's Games, but will instead opt to receive it after completing the Italian Grand Tour.
"I highly recommend it to all our riders, but for Remco it is just bad timing," Deceuninck - Quick-Step doctor Philip Jansen told Het Laatste Nieuws. "In view of the Olympics, we will certainly have it done, but not a week and a half before the Giro. It's just too close, especially after everything that has already gone wrong."
Evenepoel won't race in the build-up to the Giro d'Italia, or even recon a single stage, as he looks to improve his condition as much as possible before the start in Turin on May 8. Having already ruled himself out of contention for the maglia rosa, having been one of the pre-race favourites for the 2020 editions before his season was cut short, Evenepoel will focus on the Olympic Games as his main goal for the year.
>>> ‘Olympics can’t stop athletes taking a knee,’ says Callum Skinner
While the Belgian will receive a vaccination between the end of the Giro and the Olympic Games, medical tests have revealed Evenepoel has a large number of coronavirus antibodies already, suggesting he had an asoymptomatic Covid-19 infection at some point in the past year.
"Remco already has a high number of antibodies in his body. He already had those last year and they have remained sky-high," Jansen explained.
Get The Leadout Newsletter
The latest race content, interviews, features, reviews and expert buying guides, direct to your inbox!
"It is not clear to us exactly when [these antibodies began to appear]. He has never been ill. There's also no-one in his direct circle who contracted an infection. But we do see antibodies appear more often in people who have experienced the virus asymptomatically."
Thank you for reading 20 articles this month* Join now for unlimited access
Enjoy your first month for just £1 / $1 / €1
*Read 5 free articles per month without a subscription
Join now for unlimited access
Try first month for just £1 / $1 / €1
Jonny was Cycling Weekly's Weekend Editor until 2022.
I like writing offbeat features and eating too much bread when working out on the road at bike races.
Before joining Cycling Weekly I worked at The Tab and I've also written for Vice, Time Out, and worked freelance for The Telegraph (I know, but I needed the money at the time so let me live).
I also worked for ITV Cycling between 2011-2018 on their Tour de France and Vuelta a España coverage. Sometimes I'd be helping the producers make the programme and other times I'd be getting the lunches. Just in case you were wondering - Phil Liggett and Paul Sherwen had the same ham sandwich every day, it was great.
-
Knog Blinder 1300 review - excellent visibility for you and other road users
Solid performance, great mounting options and a respectable price point make the Blinder a great competitor for long nights this winter
By Joe Baker Published
-
Everything you want to know about the Q Factor
What it is and why it matters, how to measure it, what the Q stands for, and more
By Tyler Boucher Published